Petach Tikva, Israel

E Itzhak Lerner

This inventor holds 11 USPTO granted patents and 1 published patent application. Top assignee: Teva Pharmaceutical Industries Limited. Active years: 2005-2016.

USPTO Granted Patents = 11 

% Patents Active = 18.2

Average Co-Inventor Count = 3.9

ph-index = 5

Forward Citations = 274(Granted Patents)


Company Filing History:


Years Active: 2005-2016

Loading Chart...
11 patents (USPTO):Explore Patents

Title: E Itzhak Lerner: Innovator in Pharmaceutical Formulations

Introduction

E Itzhak Lerner is a prominent inventor based in Petach Tikva, Israel. He has made significant contributions to the field of pharmaceuticals, particularly in the formulation of medications. With a total of 11 patents to his name, Lerner's work has had a substantial impact on drug delivery and bioavailability.

Latest Patents

Among his latest innovations are improved formulations of 6-mercaptopurine. These formulations exhibit better bioavailability and faster dissolution compared to previous versions. This advancement is crucial for enhancing the effectiveness of treatments that utilize this medication.

Career Highlights

Lerner is associated with Teva Pharmaceutical Industries Limited, a leading global pharmaceutical company. His work at Teva has allowed him to focus on developing innovative solutions that address critical healthcare needs. His expertise in pharmaceutical formulations has positioned him as a key player in the industry.

Collaborations

Throughout his career, Lerner has collaborated with notable colleagues, including Moshe Flashner-Barak and Vered Rosenberger. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

E Itzhak Lerner's contributions to pharmaceutical formulations demonstrate his commitment to improving drug efficacy and patient outcomes. His innovative work continues to influence the field and pave the way for future advancements in medication development.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…